In conclusion, we demonstrated that synaptophysin expression in conventional colorectal adenocarcinomas, in contrast to colorectal MANECs, is not associated with a significantly poorer clinical outcome when compared to conventional adenocarcinomas without synaptophysin expression. This evidence concerns the gene SYP and medical procedure.